Laksh Aithani Founder of CHARM Therapeutics Backed byF-PrimeKhosla VenturesNew Enterprise AssociatesSR OneSamir KaulScott SandellSimeon GeorgeStephen Knight LinkedIn SourcesCHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML — 2025-09 Browse all founders · Browse investors
